H. Yon
2015
Citations
0
Influential Citations
0
Citations
Quality indicators
Journal
Anhui Medical and Pharmaceutical Journal
Abstract
Objective To observe clinical efficacies of repirinast for treatment of cough variant asthma( CVA) in children. Methods From February 2012 to March 2014 in Wuxi Children's Hospital,120 children with CVA were randomly assigned into research group( 60 cases) and control group( 60 cases). On the basis of conventional therapy,the control group received montelukast,while the research group was given repirinast. The efficacy and adverse reactions were observed in the two groups. Results There were not significant differences in efficacy,improvement of lung function,adverse events and recurrence rate between the two groups( P 0. 05). Conclusions Repirinast can achieve the same efficacy as montelukast in the treatment of children with CVA,which has the advantages of low recurrence rate as well as insignificant adverse reactions and is worthy to be promoted and applied in clinic.